Drug Use During Pregnancy: Validating the Drug Abuse Screening Test Against Physiological Measures
Drug Use During Pregnancy: Validating the Drug Abuse Screening Test Against Physiological Measures
复制标题
DOI：
10.1037/a0021741
复制
发表时间：
2010-12-01
影响因子：
3.4
通讯作者：
Ondersma, Steven J.
中科院分区：
文献类型：
--
作者：
Grekin, Emily R.;Svikis, Dace S.;Ondersma, Steven J.
本研究使用头发和尿液样本作为标准变量，检查药物滥用筛查试验（DAST-10）识别产前药物使用的能力。此外，这项研究是第一次使用“最佳做法”，如匿名。ACASI技术和书面筛选，以促进在这一弱势群体中的披露。300名低收入的产后妇女（90.3%为非洲裔美国人）在分娩后从医院病房招募。参与包括（a）完成包含DAST-I 0的计算机化评估组合和（B）提供尿液和毛发样本。百分之二十四的样本有一个积极的药物筛选。DAST-10的灵敏度仅为0.47。19%的样本有阳性毒理学筛查，但否认在DAST-10上使用药物。研究结果表明，简短的药物使用筛查可能对孕妇的效用有限，通过保证和匿名来促进披露的努力在这一人群中不太可能是足够的。
This study examined the ability of the Drug Abuse Screening Test (DAST-10) to identify prenatal drug use using hair and urine samples as criterion variables. In addition, this study was the first to use "best practices," such as anonymity. ACASI technology, and a written screener, to facilitate disclosure in this vulnerable population. 300 low-income, post-partum women (90.3% African-American) were recruited from their hospital rooms after giving birth. Participation involved (a) completing a computerized assessment battery that contained the DAST-I 0 and (b) providing urine and hair samples. Twenty-four percent of the sample had a positive drug screen. The sensitivity of the DAST-10 was only .47. Nineteen percent of the sample had a positive toxicology screen but denied drug use on the DAST-10. Findings suggest that brief drug use screeners may have limited utility for pregnant women and that efforts to facilitate disclosure via reassurance and anonymity are unlikely to be sufficient in this population.